FilingSEC EDGAR8-K
BioCardia to Present CardiAMP HF II Clinical Trial Design at HFSA Meeting
· SEC accepted
StageClinical Presentation
Filing content
BioCardia announced it will present the design and scientific rationale for its CardiAMP HF II clinical trial at the upcoming Heart Failure Society of America Annual Scientific Meeting.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…